Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  557 results for ""CYTOCHROME P-450 CYP2C19""

Your Filters

Subject : ticlopidine
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

COX-1, COX-2 and CYP2C19 variations may be related to cardiovascular events due to acetylsalicylic acid resistance.

  • Authors : Kirac D; Department of Medical Biology, Faculty of Medicine, Yeditepe University, Istanbul, Turkey. .; Yaman AE

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/genetics ; Cyclooxygenase 1*/Cyclooxygenase 1*/Cyclooxygenase 1*/genetics

  • Source: Molecular biology reports [Mol Biol Rep] 2022 Apr; Vol. 49 (4), pp. 3007-3014. Date of Electronic Publication: 2022 Jan 09.Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4978

Record details

Read More Add to Saved list
×
Academic Journal

Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.

  • Authors : Lin J; Department of Neurology, Third Affiliated Hospital of Wenzhou Medical University, Ruian, 325200, Zhejiang, China.; Han Z

Subjects: Pharmacogenomic Variants*; Aspirin/Aspirin/Aspirin/*therapeutic use ; Brain Ischemia/Brain Ischemia/Brain Ischemia/*drug therapy

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2018 Sep; Vol. 74 (9), pp. 1131-1140. Date of Electronic Publication: 2018 May 26.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of CYP2C19 genotype in stroke or transient ischemic attack patients treated with clopidogrel monotherapy or clopidogrel plus aspirin: Protocol for a systemic review and meta-analysis.

  • Authors : Yao JC; Department of Pharmacy, Shanghai Pudong New Area Gongli Hospital Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.; Cui M

Subjects: Aspirin*/Aspirin*/Aspirin*/adverse effects ; Aspirin*/Aspirin*/Aspirin*/therapeutic use ; Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/genetics

  • Source: Medicine [Medicine (Baltimore)] 2018 Jun; Vol. 97 (24), pp. e11060.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.

  • Authors : Zhong Z; Center for Cardiovascular Diseases, Meizhou People's Hospital (Huangtang Hospital), Meizhou Hospital Affiliated to Sun Yat-sen University, Meizhou, 514031, People's Republic of China.; Hou J

Subjects: Drug-Eluting Stents* ; Pharmacogenomic Variants* ; Polymorphism, Genetic*

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2018 Apr; Vol. 74 (4), pp. 423-431. Date of Electronic Publication: 2017 Dec 14.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

Read More Add to Saved list
×
Academic Journal

Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.

  • Authors : Novkovic M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, P.O. Box 23, 11010, Belgrade, Serbia.; Matic D

Subjects: Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects ; Pharmacogenomic Variants* ; Polymorphism, Single Nucleotide*

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2018 Apr; Vol. 74 (4), pp. 443-451. Date of Electronic Publication: 2017 Dec 19.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

Read More Add to Saved list
×
Academic Journal

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI).

  • Authors : Chen S; Department of Heart Center, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland).; Zhang Y

Subjects: Adenosine/Adenosine/Adenosine/*analogs & derivatives ; Coronary Disease/Coronary Disease/Coronary Disease/*drug therapy ; Coronary Disease/Coronary Disease/Coronary Disease/*surgery

  • Source: Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2017 Aug 07; Vol. 23, pp. 3824-3830. Date of Electronic Publication: Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 9609063 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Personalizing antiplatelet prescribing using genetics for patients undergoing percutaneous coronary intervention.

  • Authors : Cavallari LH; a Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics , University of Florida College of Pharmacy , Gainesville , FL , USA.

Subjects: Biomarkers, Pharmacological* ; Percutaneous Coronary Intervention* ; Polymorphism, Genetic*

  • Source: Expert review of cardiovascular therapy [Expert Rev Cardiovasc Ther] 2017 Aug; Vol. 15 (8), pp. 581-589. Date of Electronic Publication: 2017 Jul 19.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101182328 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Impact of CYP2C19 Loss-of-Function Polymorphisms, Clinical, and Demographic Variables on Platelet Response to Clopidogrel Evaluated Using Impedance Aggregometry.

  • Authors : Mărginean A; 1 Department of Laboratory Medicine, University of Medicine and Pharmacy Tîrgu Mureş, Tîrgu Mureş, Romania.; Bănescu C

Subjects: Blood Platelets/Blood Platelets/Blood Platelets/*drug effects ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Polymorphism, Genetic/Polymorphism, Genetic/Polymorphism, Genetic/*physiology

  • Source: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2017 Apr; Vol. 23 (3), Publisher: Sage Publications Country of Publication: United States NLM ID: 9508125 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy.

  • Authors : Tantray JA; Department of Zoology, Osmania University, Hyderabad, Telangana, India; Genetics Department, Bhagwan Mahavir Medical Research Centre, 10-1-1, Mahavir Marg, AC Guards, Hyderabad 500004, Telangana, India.

Subjects: Polymorphism, Single Nucleotide*; Coronary Artery Disease/Coronary Artery Disease/Coronary Artery Disease/*therapy ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics

  • Source: International journal of cardiology [Int J Cardiol] 2017 Feb 15; Vol. 229, pp. 113-118. Date of Electronic Publication: 2016 Nov 11.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Identifying clinically relevant sources of variability: The clopidogrel challenge.

  • Authors : Samant S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, University of Florida at Lake Nona, Orlando, Florida, USA.; Jiang XL

Subjects: Body Mass Index*; Aging/Aging/Aging/*physiology ; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2017 Feb; Vol. 101 (2), pp. 264-273. Date of Electronic Publication: 2016 Oct 11.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
  • 1-10 of  557 results for ""CYTOCHROME P-450 CYP2C19""